Need I say more?

Walgreens (WAG) comments on Wal-Mart (WMT) “will put them out of business strategy” on the company conference call:

  • For the 291 drugs that Wal-Mart will sell for $4, the average co-pay at Walgreens is $5.30 and for Medicare Part D patients it’s only $3.18.
  • Wal-Mart’s program covers less than 300 generic medications while Walgreens pharmacies’ stock has about 1800 different generics.
  • Over the years, WAG’s convenience, locations, and services have proven to be bigger factors for its patients than a few dollars in price difference – the point I argued in this article

    Need I say more?

  • Vitaliy Katsenelson

    I am the CEO at IMA, which is anything but your average investment firm. (Why? Get our company brochure here, or simply visit our website).

    In a brief moment of senility, Forbes magazine called me “the new Benjamin Graham.”

    I’ve written two books on investing, which were published by John Wiley & Sons and have been translated into eight languages. (I’m working on a third - you can read a chapter from it, titled “The 6 Commandments of Value Investing” here).

    And if you prefer listening, audio versions of my articles are published weekly at investor.fm.

    Don't miss new articles

    We'll let you know when we publish new articles